EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

How Three Self-Secreted Biofilm Exopolysaccharides of Pseudomonas aeruginosa, Psl, Pel, and Alginate, Can Each Be Exploited for Antibiotic Adjuvant Effects in Cystic Fibrosis Lung Infection

Jonathan Chung, Shafinaz Eisha, Subin Park, Amanda J Morris, Isaac Martin

International Journal of Molecular Sciences · 13.05.2023 · 24 (10) · 8709

DOI: 10.3390/ijms24108709 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.05.2023. Verfasst von Jonathan Chung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, Research Institute, The Hospital for Sick Children, University of Toronto, 686 Bay Street, Toronto, ON M5G 0A4,…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pseudomonas Infections. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In cystic fibrosis (CF), pulmonary infection with Pseudomonas aeruginosa is a cause of increased morbidity and mortality, especially in patients for whom infection becomes chronic and there is reliance on long-term suppressive therapies. Current antimicrobials, though varied mechanistically and by mode of delivery, are inadequate not only due to their failure to eradicate infection but also because they do not halt the progression of lung function decline over time. One of the reasons for this failure is thought to be the biofilm mode of growth of P. aeruginosa, wherein self-secreted exopolysaccharides (EPSs) provide physical protection against antibiotics and an array of niches with resulting metabolic and phenotypic heterogeneity. The three biofilm-associated EPSs secreted by P. aeruginosa (alginate, Psl, and Pel) are each under investigation and are being exploited in ways that potentiate antibiotics. In this review, we describe the development and structure of P. aeruginosa biofilms before examining each EPS as a potential therapeutic target for combating pulmonary infection with P. aeruginosa in CF, with a particular focus on the current evidence for these emerging therapies and barriers to bringing these therapies into clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisPseudomonas InfectionsHumansAnti-Bacterial AgentsPseudomonas aeruginosaAlginatesBiofilmsAdjuvants, ImmunologicAdjuvants, PharmaceuticLung

Stichwörter der Autor:innen

Pseudomonas aeruginosaalginate oligosaccharideanti-biofilmantibiotic adjunctbiofilm-degrading enzymescystic fibrosismatrix exopolysaccharides

Substanzen

Anti-Bacterial AgentsAlginatesAdjuvants, ImmunologicAdjuvants, Pharmaceutic

Autor:innen und Institutionen

  • Department of Translational Medicine, Research Institute, The Hospital for Sick Children, University of Toronto, 686 Bay Street, Toronto, ON M5G 0A4, Canada.
  • Division of Respiratory Medicine, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON M5G 1X8, Canada.

Zitieren

APA

Chung, J., Eisha, S., Park, S., Morris, A. J., & Martin, I. (2023). How Three Self-Secreted Biofilm Exopolysaccharides of Pseudomonas aeruginosa, Psl, Pel, and Alginate, Can Each Be Exploited for Antibiotic Adjuvant Effects in Cystic Fibrosis Lung Infection. International Journal of Molecular Sciences, 24(10), 8709. https://doi.org/10.3390/ijms24108709

Vancouver

Chung J, Eisha S, Park S, Morris AJ, Martin I. How Three Self-Secreted Biofilm Exopolysaccharides of Pseudomonas aeruginosa, Psl, Pel, and Alginate, Can Each Be Exploited for Antibiotic Adjuvant Effects in Cystic Fibrosis Lung Infection. International Journal of Molecular Sciences. 2023;24(10):8709. doi:10.3390/ijms24108709

BibTeX
@article{Chung2023,
  author = {Chung, Jonathan and Eisha, Shafinaz and Park, Subin and Morris, Amanda J and Martin, Isaac},
  title = {How Three Self-Secreted Biofilm Exopolysaccharides of Pseudomonas aeruginosa, Psl, Pel, and Alginate, Can Each Be Exploited for Antibiotic Adjuvant Effects in Cystic Fibrosis Lung Infection},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {10},
  pages = {8709},
  doi = {10.3390/ijms24108709}
}
Kostenlos starten →